Works matching IS 02780232 AND DT 2017 AND VI 35
Results: 671
Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hyponatremia in a multiple myeloma patient treated with bortezomib.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Variation in the use of up-front chemotherapy for indolent B-cell lymphomas and chronic lymphocytic leukemia.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Autoimmune hemolytic anemia after nivolumab treatment in Hodgkin lymphoma responsive to immunosuppressive treatment. A case report.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Independent prognostic impact of CD15 on complete remission achievement in patients with acute myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B-cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group-37 study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Reporting real-life experience with drugs in lymphoma patients.
- Published in:
- 2017
- By:
- Publication type:
- Letter
RUNX1 amplification in AML with myelodysplasia-related changes and ring 21 chromosomes.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Risk of hemophagocytic lymphohistiocytosis in adults with fevers of unknown origin: the clinical utility of a new scoring system on early detection.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical impact of early recovery of peripheral blood absolute lymphocyte count after frontline autologous stem cell transplantation for diffuse large B-cell lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Occult recurrence of monomorphic epitheliotropic intestinal T-cell lymphoma and the role of MATK gene expression in diagnosis.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
The bendamustine plus rituximab regimen is active against primary nodal marginal zone B-cell lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Serum free immunoglobulin light chain fingerprint identifies a subset of newly diagnosed multiple myeloma patients with worse outcome.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Bendamustine-associated infections-systematic review and meta-analysis of randomized controlled trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Proteasome inhibitors in AL amyloidosis: focus on mechanism of action and clinical activity.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Human myeloid inhibitory C-lectin: a highly specific and stable acute myeloid leukemia marker.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Bone mineral density utilization in patients with newly diagnosed multiple myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach.
- Published in:
- 2017
- By:
- Publication type:
- journal article
FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Vemurafenib in combination with cobimetinib in relapsed and refractory extramedullary multiple myeloma harboring the BRAF V600E mutation.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Primary cardiac lymphoma: diagnosis, treatment and outcome in a modern series.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The effect of microenvironmental factors on the development of myeloma cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Issue Information.
- Published in:
- Hematological Oncology, 2017, v. 35, n. 4, p. 395, doi. 10.1002/hon.2358
- Publication type:
- Article
Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Paclitaxel-releasing mesenchymal stromal cells inhibit the growth of multiple myeloma cells in a dynamic 3D culture system.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Increased fibrinogen levels at diagnosis are associated with adverse outcome in patients with acute myeloid leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Active acute leukaemia: should transplant be offered to all patients?
- Published in:
- 2017
- By:
- Publication type:
- journal article
Trichosporon: another yeast-like organism responsible for immune reconstitution inflammatory syndrome in patients with hematological malignancy.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
First-line therapy for chronic lymphocytic leukemia in patients older than 79 years is feasible and achieves good results: A FILO retrospective study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Outpatient experience with biosimilar filgrastim in patients with lymphoid neoplasm: Lessons from daily clinical practice.
- Published in:
- 2017
- By:
- Publication type:
- clinical trial
Treatment of secondary central nervous system lymphoma with intrathecal rituximab, high-dose methotrexate, and R-DHAP followed by autologous stem cell transplantation: results of the HOVON 80 phase 2 study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical characteristics and survival outcome of primary effusion lymphoma: A review of 105 patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
PD1 and PDL1 expression in primary central nervous system diffuse large B-cell lymphoma are frequent and expression of PD1 predicts poor survival.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Serum level of CXCL10 is associated with inflammatory prognostic biomarkers in patients with diffuse large B-cell lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Role of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in evaluating breast mucosa-associated lymphoid tissue lymphoma: A case series.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Mortality and survival patterns of childhood lymphomas: geographic and age-specific patterns in Southern-Eastern European and SEER/US registration data.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Relationship between venetoclax exposure, rituximab coadministration, and progression-free survival in patients with relapsed or refractory chronic lymphocytic leukemia: demonstration of synergy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Epidemiology and risk factors of invasive fungal infections in a large cohort of patients with chronic lymphocytic leukemia.
- Published in:
- 2017
- By:
- Publication type:
- Letter
Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM): a practical guide to management.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Results from a monoinstitutional cohort analysis of long-term survivors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- clinical trial
Mean platelet volume as a predictive marker for venous thromboembolism and mortality in patients treated for diffuse large B-cell lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Polymorphism of IL-10 receptor β affects the prognosis of multiple myeloma patients treated with thalidomide and/or bortezomib.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Increase of CIK cell efficacy by upregulating cell surface MICA and inhibition of NKG2D ligand shedding in multiple myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article